Certara acquires Pinnacle 21, a leader in standardization software for clinical data in medicine
Certara, Inc. (NASDAQ: CERT), a global leader in biomimicry, announced today that it has signed a definitive agreement to acquire Pinnacle 21 for $310 million in cash and stock. Pinnacle 21’s so...